Bisocard

Package leaflet: Information for the patient

Warning! Keep this leaflet! Information on the immediate packaging in a foreign language.
Bisocard (Bisocard 5 mg), 5 mg, film-coated tablets
Bisoprolol fumarate
Bisocard and Bisocard 5 mg are different brand names of the same medicine.
Please read this leaflet carefully before using the medicine, as it contains
important information for the patient.

• Keep this leaflet so that you can read it again if necessary.
• If you have any doubts, consult your doctor or pharmacist.
• This medicine has been prescribed for a specific individual. Do not pass it on to others. This medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any adverse reactions, including any not listed in this leaflet, inform your doctor or pharmacist. See section 4.

Table of contents of the leaflet

1. What Bisocard is and what it is used for
2. Important information before taking Bisocard
3. How to take Bisocard
4. Possible side effects
5. How to store Bisocard
6. Contents of the pack and other information

1. What Bisocard is and what it is used for

Bisocard is a medicine that selectively blocks beta-adrenergic receptors (present, among others, in the heart and blood vessels). It has beneficial effects, among others, in patients with heart failure and symptomatic stable systolic dysfunction, protecting the heart from excessive activity.
Bisocard is used in the treatment of:

• hypertension;
• angina pectoris (chest pain due to inadequate oxygen supply to the heart);
• stable, moderate to severe chronic heart failure with impaired left ventricular systolic function (ejection fraction ≤ 35% as assessed by echocardiography), in combination with ACE inhibitors (angiotensin-converting enzyme), diuretics, and, if necessary, digitalis glycosides.

2. Important information before using Bisocard

When not to use Bisocard:

• if the patient is allergic to bisoprolol fumarate or any of the other ingredients of this medicine (listed in section 6);
• if the patient has cardiogenic shock – a severe heart condition with rapid, weak pulse, low blood pressure, cold and clammy skin, weakness, and fainting;
• if the patient has severe bronchial asthma or severe chronic obstructive pulmonary disease (COPD);
• if the patient has a slow heart rate (less than 60 beats per minute) – consult a doctor if in doubt;
• if the patient has very low blood pressure;
• if the patient has severe peripheral circulatory disorders (which may cause tingling, paleness or blueness of fingers and toes);
• if the patient has heart rhythm disorders – slow or irregular heartbeat;
• if the patient has developed acute heart failure or worsening of existing heart failure requiring intravenous administration of drugs that increase heart contractility;
• if the patient is currently taking floctafenic acid (a non-steroidal anti-inflammatory drug) or sultopride (a medicine used to treat psychiatric disorders);
• if the patient has metabolic acidosis (a condition in which blood pH is too low);
• if the patient has an untreated phaeochromocytoma (a tumour of the adrenal gland, also known as chromaffinoma).

Warnings and precautions
Before starting treatment with Bisocard, consult your doctor if:

• the patient has mild bronchial asthma or chronic obstructive pulmonary disease – bronchodilator therapy should be continued and the dose may need to be increased;
• the patient has diabetes – Bisocard may mask symptoms of hypoglycaemia (low blood glucose levels);
• the patient is on a strict diet;
• the patient has first-degree atrioventricular block (a heart conduction disorder);
• the patient has Prinzmetal's angina (chest pain caused by spasm of the coronary arteries supplying blood to the heart muscle);
• the patient has mild peripheral circulatory disorders;
• the patient has thyroid dysfunction (bisoprolol may mask some symptoms of hyperthyroidism, such as rapid heartbeat);
• the patient has a chromaffinoma (adrenal gland tumour) – the doctor must initiate appropriate treatment before prescribing Bisocard;
• the patient has (or has had in the past) psoriasis (a recurrent skin disease characterized by reddish-brown patches and skin scaling);
• the patient has ever experienced allergic reactions – Bisocard may increase sensitivity to allergens and intensify allergic reactions;
• the patient is undergoing desensitization therapy (treatment aimed at reducing allergy, e.g. to bee or wasp stings);
• the patient is scheduled for surgery – Bisocard may alter the body's response to anaesthetic drugs.

Treatment of heart failure with Bisocard requires regular medical supervision. This is essential, particularly at the beginning of treatment, during dose escalation, and when discontinuing therapy.
Consult your doctor if any of the above warnings apply to the patient or applied in the past.

Children and adolescents
Due to lack of experience with the use of bisoprolol in children and adolescents, its use is not recommended in this age group.

Bisocard and other medicines
Inform your doctor or pharmacist about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take.

The doctor will not recommend using Bisocard if the patient is taking:

• floctafenic acid (a non-steroidal anti-inflammatory drug) or sultopride (a medicine used to treat psychiatric disorders).

Do not take the following medicines together with Bisocard without specific medical advice:

• certain medicines used to treat heart rhythm disorders (Class I antiarrhythmics such as quinidine, disopyramide, lidocaine, phenytoin, flecainide, propafenone);
• certain medicines used to treat high blood pressure, angina, or heart rhythm disorders (calcium channel blockers such as verapamil and diltiazem);
• certain medicines used to treat high blood pressure, such as clonidine, methyldopa, moxonidine, rilmenidine. However, do not stop taking these medicines without consulting your doctor.

Before taking any of the following medicines together with Bisocard, talk to your doctor – the doctor may recommend more frequent monitoring of the patient's condition:

• certain medicines used to treat high blood pressure or angina (dihydropyridine calcium channel blockers such as felodipine and amlodipine);
• certain medicines used to treat heart rhythm disorders (Class III antiarrhythmics such as amiodarone);
• locally applied beta-blockers (such as eye drops containing timolol, used in glaucoma treatment);
• certain medicines used to treat, for example, Alzheimer's disease or glaucoma (parasympathomimetics such as donepezil or pilocarpine), or medicines used in acute heart conditions (sympathomimetics such as isoprenaline and dobutamine);
• antidiabetic medicines, including insulin;
• anaesthetic agents (e.g. during surgery);
• cardiac glycosides, used in the treatment of heart failure;
• non-steroidal anti-inflammatory drugs (NSAIDs), used to treat inflammatory conditions and relieve pain (e.g. ibuprofen and diclofenac);
• all medicines that may lower blood pressure, either as a desired or adverse effect, such as antihypertensive drugs, certain tricyclic antidepressants (e.g. imipramine, amitriptyline), certain antiepileptic drugs or general anaesthetics (barbiturates such as phenobarbital), and certain antipsychotics used in disorders involving loss of contact with reality (phenothiazine derivatives such as levomepromazine);
• mefloquine, used for prevention and treatment of malaria;
• antidepressants known as monoamine oxidase inhibitors (MAOIs), such as moclobemide (except MAO-B inhibitors);
• rifampicin (an antibiotic);
• ergotamine derivatives (used to treat migraine).

Bisocard and alcohol
Alcohol may worsen dizziness and drowsiness caused by Bisocard. In such cases, alcohol consumption should be avoided.

Pregnancy and breastfeeding
There is a risk that using Bisocard during pregnancy may harm the unborn child.
If the patient is pregnant, breastfeeding, suspects she may be pregnant, or is planning to become pregnant, she should consult her doctor or pharmacist before using this medicine. The doctor will decide whether Bisocard can be used during pregnancy.
It is not known whether bisoprolol passes into human breast milk; therefore, breastfeeding is not recommended during treatment with Bisocard.

Driving and operating machinery
Depending on the individual patient's response to treatment, the ability to drive or operate machinery may be impaired. This should be considered, particularly at the beginning of treatment, after increasing the dose, when changing medication, or when consuming alcohol.

Bisocard contains lactose monohydrate
If the patient has previously been diagnosed with intolerance to certain sugars, the patient should consult their doctor before taking this medicine.

Bisocard contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".

3. How to use Bisocard

This medicine should always be taken as directed by your doctor.
If in doubt, consult your doctor or pharmacist.
Bisocard is available in the following doses: 5 mg, 10 mg.
The tablets should be taken in the morning. They may be taken either during or before a meal.
Swallow the tablets whole with liquid. Do not crush or chew them.
Bisocard should be taken once daily, at the same time each day.

Hypertension and angina pectoris
The dose is individually determined by the doctor for each patient, based on heart rate and treatment efficacy.
The recommended starting dose is 5 mg once daily. If necessary, the dose may be increased to 10 mg once daily. Your doctor may decide to increase or decrease this dose.
The maximum recommended dose is 20 mg once daily.
In some milder cases of hypertension, a dose of 2.5 mg once daily may be sufficient.
Discontinuation of Bisocard or dose reduction should be carried out gradually, especially in patients with ischemic heart disease.

Renal or hepatic impairment
In patients with severe renal or hepatic impairment, the maximum dose is 10 mg per day.

Elderly patients
Dose adjustment is usually not necessary.

Heart failure (reduced cardiac contractility)
Your doctor will start treatment with a low dose of bisoprolol and gradually increase it—your doctor will decide how to adjust the dose. Typically, this is done as follows:

• 1.25 mg bisoprolol once daily for 1 week
• 2.5 mg bisoprolol once daily for 1 week
• 3.75 mg bisoprolol once daily for 1 week
• 5 mg bisoprolol once daily for 4 weeks
• 7.5 mg bisoprolol once daily for 4 weeks
• 10 mg bisoprolol once daily for maintenance (chronic) treatment.

The maximum recommended daily dose is 10 mg bisoprolol.
Depending on how well the medicine is tolerated, your doctor may recommend extending the interval before the next dose increase. If the condition worsens or if the medicine is not well tolerated, it may be necessary to reduce the dose again or discontinue treatment. In some patients, a maintenance dose lower than 10 mg bisoprolol may be sufficient.
Your doctor will determine the appropriate course of action.
If discontinuation of treatment becomes necessary, your doctor will usually recommend gradually reducing the dose. Otherwise, the condition may worsen.

Hepatic or renal impairment
Your doctor will increase the dose particularly cautiously.

Elderly patients
Dose adjustment is usually not necessary.

Duration of treatment
Treatment with Bisocard is long-term. Continue taking this medicine for as long as your doctor advises.

Taking more Bisocard than recommended
If you take more than the recommended dose, contact your doctor immediately or go to the nearest hospital emergency department. Take any remaining tablets or this leaflet with you so that medical staff know which medicine has been taken.
Symptoms of overdose may include dizziness, feeling faint, fatigue, shortness of breath, and/or wheezing. There may also be bradycardia (slow heart rate), hypotension, bronchospasm, acute heart failure, or seizures (caused by low blood glucose levels).

Missing a dose of Bisocard
Do not take a double dose to make up for a missed dose. If you forget to take a dose at the scheduled time, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose.

Stopping Bisocard
Do not stop taking Bisocard unless your doctor advises you to do so. Abruptly stopping this medicine may worsen the symptoms for which it was prescribed. Discontinuation of the medicine and dose reduction should be done gradually, especially in patients with ischemic heart disease.

If you have any further questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.
The adverse effects listed below are classified according to their frequency of occurrence as follows:

Very common (may occur in at least 1 in 10 people):

• slow heart rate (in patients with chronic heart failure).

Common (may occur in less than 1 in 10 people):

• dizziness, headache;
• worsening of heart failure (in patients with chronic heart failure);
• sensation of coldness or numbness in the extremities (hands or feet);
• gastrointestinal disturbances such as nausea, vomiting, diarrhoea, constipation;
• very low blood pressure (hypotension), especially in patients with heart failure;
• feeling of fatigue, exhaustion (asthenia) in patients with chronic heart failure.

Uncommon (may occur in less than 1 in 100 people):

• sleep disorders, depression;
• irregular heart rate or worsening of heart failure (in patients with hypertension or angina pectoris);
• slow heart rate (in patients with hypertension or angina pectoris);
• low blood pressure occurring upon changing position from lying or sitting to standing;
• bronchospasm in patients with bronchial asthma or obstructive airway disease;
• muscle weakness and muscle cramps;
• asthenia in patients with hypertension or angina pectoris.

Rare (may occur in less than 1 in 1,000 people):

• nightmares, hallucinations;
• fainting;
• dry eyes due to reduced tear secretion (which may be particularly bothersome in patients wearing contact lenses);
• hearing disturbances;
• allergic rhinitis;
• hepatitis;
• hypersensitivity reactions such as itching, sudden skin redness, rash;
• reduced sexual function (impotence);
• increased blood lipid levels (triglycerides) and increased liver enzyme activity (AlAT, AspAT).

Very rare (may occur in less than 1 in 10,000 people):

• conjunctivitis;
• worsening of psoriasis symptoms or occurrence of similar dry, scaly rash;
• hair loss.

Reporting of adverse effects
If any adverse effects occur, including those not listed in this leaflet, inform your doctor or pharmacist. Adverse effects can be reported directly to the Department of Monitoring Adverse Drug Reactions of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Reporting adverse effects helps to gather more information on the safety of the medicine.

5. How to store Bisocard

Store below 30°C.
Keep in the original packaging to protect from light and moisture.
Keep the medicine out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the stated month.
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the packaging and other information

What Bisocard contains

• The active substance is bisoprolol fumarate. One coated tablet contains 5 mg of bisoprolol fumarate.
• Other ingredients are: monohydrate lactose, maize starch, anhydrous colloidal silicon dioxide, sodium lauryl sulfate, talc, magnesium stearate, hypromellose, polyethylene glycol 400, titanium dioxide (E 171), yellow iron oxide (E 172).

What Bisocard looks like and contents of the pack
Bisocard is a coated tablet.
Light yellow, round, biconvex tablets with a break line on one side
and the mark "5" on the other side.
The dividing groove is intended only to facilitate breaking the tablet for easier swallowing and does not serve to divide it into equal doses.
This medicine is packed in Al/PVC blisters.
Pack sizes:
30 or 60 coated tablets.
For more detailed information, please contact the responsible party or the parallel importer.
Marketing Authorisation Holder in Slovakia, country of export:
BAUSCH HEALTH IRELAND LIMITED
3013 Lake Drive
Citywest Business Campus
Dublin 24, D24PPT3
Ireland
Manufacturer:
ICN Polfa Rzeszów S.A.
Przemysłowa 2
35-959 Rzeszów
Poland
Parallel Importer:
InPharm Sp. z o.o.
Strumykowa 28/11
03-138 Warsaw
Poland
Repackaged by:
InPharm Sp. z o.o. Services sp. k.
Chełmżyńska 249
04-458 Warsaw
Poland
Marketing Authorisation Number in Slovakia, country of export: 41/0366/01-S
Parallel Import Authorisation Number: 199/24